Why optical glucose monitoring remains difficult in smartwatches

Optical glucose monitoring tries to infer glucose from how light interacts with tissue, rather than measuring glucose in a blood sample. The key takeaway is that research describes real physical and calibration challenges, but the supplied evidence does not establish a reliable optical smartwatch or prove that proposed approaches solve those problems.

Technical limitations

What could improve, and what is not yet demonstrated

The near-future directions in the supplied research are promising concepts, not validated smartwatch breakthroughs. One broad proposal is to combine noninvasive collection of body fluids with optical detection; the cited review does not report device performance, clinical testing, or smartwatch results for this direction.

Other concepts include deep-learning domain adaptation, which aims to make mid-infrared analysis less dependent on blood-sample calibration, and optical tear or contact-lens sensors. The available excerpts describe these approaches but do not establish improved calibration stability, robustness in people, or readiness for smartwatch use.^{[9][10][11][12][13]}

Overall, the reviews describe methods under study, not a sufficiently accurate and practical optical glucose monitor established for use. One review reports that precision or usability problems had prevented acceptance of noninvasive glucose-measurement products on the market; another describes variable validity and accuracy in noninvasive methods.^[14][15]

Regulatory status and practical takeaway

The FDA says standalone smartwatches and smart rings that claim to measure blood glucose without piercing the skin are not FDA-authorized, and advises people not to use them for glucose measurement. Inaccurate readings could lead to harmful treatment decisions, including an incorrect insulin or medication dose.^[16][17]

This warning concerns watches or rings that measure glucose themselves; it does not mean every wearable glucose system is unauthorized. The FDA warning distinguishes them from smartwatch apps that display readings from an authorized glucose monitor, and from other wearable monitoring systems that have received FDA authorization.^[18][19]

Bottom line: Optical sensing faces weak or confounded signals and unresolved questions about skin-tone performance and calibration drift. Proposed sensing and calibration techniques may help, but the cited evidence does not show that they have produced a clinically validated optical smartwatch; follow FDA guidance and use an authorized glucose-measuring device.^{[20][21][22][23]}